• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭和心房颤动患者的卒中发病率:一项基于人群的回顾性队列研究。

Stroke incidence in heart failure and atrial fibrillation: a population-based retrospective cohort study.

作者信息

Jones Nicholas R, Smith Margaret, Lay-Flurrie Sarah, Yang Yaling, Hobbs Richard, Taylor Clare J

机构信息

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford.

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford; NIHR Oxford Biomedical Research Centre, Oxford.

出版信息

Br J Gen Pract. 2025 Mar 27;75(753):e258-e265. doi: 10.3399/BJGP.2024.0470. Print 2025 Apr.

DOI:10.3399/BJGP.2024.0470
PMID:39778943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11920897/
Abstract

BACKGROUND

Heart failure (HF) is a risk factor for stroke among people with atrial fibrillation (AF). Prognosis following an HF diagnosis is often poor, but this is not accounted for in existing stroke risk scores.

AIM

To examine stroke incidence in people with HF and AF compared with AF alone, considering the competing risk of death.

DESIGN AND SETTING

A population-based retrospective cohort study in English primary care, linked to secondary care Hospital Episode Statistics data.

METHOD

In total, 2 381 941 people aged ≥45 years were identified in the Clinical Practice Research Datalink from 2000 to 2018. HF and AF were included as time-varying covariates; 69 575 had HF and AF, 141 562 had AF alone, and 91 852 had HF alone. Hazard ratios (HRs) for first stroke are reported using the Cox model and the Fine-Gray model.

RESULTS

Over median follow-up of 6.62 years, 93 665 people (3.9%) had a first stroke and 314 042 (13.2%) died. Over half (51.3%) of those with HF, with or without AF, died. In the fully adjusted Cox model, relative stroke risk was highest among people with AF alone (HR 2.43, 95% confidence interval [CI] = 2.38 to 2.48), followed by HF and AF (HR 2.20, 95% CI = 2.14 to 2.26). The cumulative incidence function of stroke was also highest among those with AF only once accounting for the competing risk of all-cause mortality. In a Fine-Gray model, the relative risk of stroke was similar for people with AF alone (HR 2.38, 95% CI = 2.33 to 2.43), but there was significant attenuation among those with HF and AF (HR 1.48, 95% CI = 1.44 to 1.53).

CONCLUSION

HF is an aetiological risk factor for stroke, yet its prognostic significance is reduced by the high incidence of death. Use of the CHADS-VASc score may overestimate stroke incidence in some people with HF, particularly those with a poor prognosis.

摘要

背景

心力衰竭(HF)是心房颤动(AF)患者发生中风的危险因素。HF诊断后的预后通常较差,但现有中风风险评分未考虑这一点。

目的

在考虑死亡竞争风险的情况下,比较HF合并AF患者与单纯AF患者的中风发病率。

设计与背景

一项基于人群的回顾性队列研究,数据来源于英国初级医疗,并与二级医疗的医院事件统计数据相关联。

方法

2000年至2018年期间,在临床实践研究数据链中总共识别出2381941名年龄≥45岁的人。HF和AF被视为随时间变化的协变量;69575人患有HF和AF,141562人仅患有AF,91852人仅患有HF。使用Cox模型和Fine-Gray模型报告首次中风的风险比(HRs)。

结果

在中位随访6.62年期间,93665人(3.9%)发生了首次中风,314042人(13.2%)死亡。无论有无AF,超过一半(51.3%)的HF患者死亡。在完全调整的Cox模型中,单纯AF患者的相对中风风险最高(HR 2.43,95%置信区间[CI]=2.38至2.48),其次是HF合并AF患者(HR 2.20,95%CI=2.14至2.26)。仅考虑全因死亡率的竞争风险时,中风的累积发病率函数在仅患有AF的患者中也最高。在Fine-Gray模型中,单纯AF患者的中风相对风险相似(HR 2.38,95%CI=2.33至2.43),但HF合并AF患者的风险显著降低(HR 1.48,95%CI=1.44至1.53)。

结论

HF是中风的病因性危险因素,但其预后意义因高死亡率而降低。CHADS-VASc评分的使用可能会高估一些HF患者的中风发病率,尤其是那些预后较差的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bb4/11961173/57a0b486abe7/bjgpapr-2025-75-753-e258-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bb4/11961173/e4f468adab23/bjgpapr-2025-75-753-e258-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bb4/11961173/57a0b486abe7/bjgpapr-2025-75-753-e258-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bb4/11961173/e4f468adab23/bjgpapr-2025-75-753-e258-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bb4/11961173/57a0b486abe7/bjgpapr-2025-75-753-e258-2.jpg

相似文献

1
Stroke incidence in heart failure and atrial fibrillation: a population-based retrospective cohort study.心力衰竭和心房颤动患者的卒中发病率:一项基于人群的回顾性队列研究。
Br J Gen Pract. 2025 Mar 27;75(753):e258-e265. doi: 10.3399/BJGP.2024.0470. Print 2025 Apr.
2
Heart failure and major haemorrhage in people with atrial fibrillation.心房颤动患者的心力衰竭和主要出血。
Open Heart. 2024 Oct 14;11(2):e002975. doi: 10.1136/openhrt-2024-002975.
3
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
4
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).心房颤动对心力衰竭患者死亡率、卒中风险及生活质量评分的影响(源自心房颤动更优治疗结局注册研究[ORBIT-AF])
Am J Cardiol. 2017 Jun 1;119(11):1763-1769. doi: 10.1016/j.amjcard.2017.02.050. Epub 2017 Mar 16.
5
Clinical outcomes in heart failure patients with and without atrial fibrillation receiving sodium-glucose cotransporter-2 inhibitor.钠-葡萄糖共转运蛋白 2 抑制剂治疗伴或不伴心房颤动的心力衰竭患者的临床结局。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):1977-1986. doi: 10.1007/s00210-023-02425-5. Epub 2023 Mar 7.
6
The CHADS-VASc Score for Risk Stratification of Stroke in Heart Failure With-vs-Without Atrial Fibrillation.心力衰竭伴或不伴心房颤动患者中卒中风险分层的 CHADS-VASc 评分。
Am J Cardiol. 2021 Sep 15;155:72-77. doi: 10.1016/j.amjcard.2021.05.004. Epub 2021 Jul 14.
7
Prognoses and risk stratification of thrombus-associated events in heart failure patients without atrial fibrillation.无房颤的心力衰竭患者血栓相关事件的预后及风险分层
ESC Heart Fail. 2024 Dec;11(6):3687-3701. doi: 10.1002/ehf2.14952. Epub 2024 Jul 9.
8
Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community.心力衰竭患者心房颤动的发生率和影响:大型社区的真实世界数据。
ESC Heart Fail. 2022 Dec;9(6):4230-4239. doi: 10.1002/ehf2.14124. Epub 2022 Sep 16.
9
Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter.典型心房扑动经导管射频消融术后发生心房颤动、中风及死亡的风险
Clin Res Cardiol. 2014 Jul;103(7):543-52. doi: 10.1007/s00392-014-0682-6. Epub 2014 Feb 25.
10
Predicting stroke and death in patients with heart failure using CHADS-VASc score in Asia.采用 CHADS-VASc 评分预测亚洲心力衰竭患者的中风和死亡风险。
BMC Cardiovasc Disord. 2019 Aug 8;19(1):193. doi: 10.1186/s12872-019-1178-0.

本文引用的文献

1
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
2
Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.全球范围内房颤患者抗凝处方模式随时间的变化。
J Arrhythm. 2021 Jul 10;37(4):990-1006. doi: 10.1002/joa3.12588. eCollection 2021 Aug.
3
Concordance in the recording of stroke across UK primary and secondary care datasets: a population-based cohort study.
英国初级和二级医疗保健数据集中风记录的一致性:一项基于人群的队列研究。
BJGP Open. 2021 Apr 26;5(2). doi: 10.3399/BJGPO.2020.0117. Print 2021 Apr.
4
Long-Term Risk of Stroke and Poststroke Outcomes in Patients with Heart Failure: Two Nationwide Studies.心力衰竭患者中风的长期风险及中风后结局:两项全国性研究
Clin Epidemiol. 2020 Nov 5;12:1235-1244. doi: 10.2147/CLEP.S261179. eCollection 2020.
5
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
6
A review of the use of time-varying covariates in the Fine-Gray subdistribution hazard competing risk regression model.时变协变量在 Fine-Gray 亚分布风险竞争风险回归模型中的应用综述。
Stat Med. 2020 Jan 30;39(2):103-113. doi: 10.1002/sim.8399. Epub 2019 Oct 29.
7
Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis.社区慢性心力衰竭患者的生存状况:系统评价和荟萃分析。
Eur J Heart Fail. 2019 Nov;21(11):1306-1325. doi: 10.1002/ejhf.1594. Epub 2019 Sep 16.
8
Simulation shows undesirable results for competing risks analysis with time-dependent covariates for clinical outcomes.模拟显示,对于具有时间依赖性协变量的临床结局竞争风险分析,结果不理想。
BMC Med Res Methodol. 2018 Jul 16;18(1):79. doi: 10.1186/s12874-018-0535-5.
9
Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation.在事件发生时间分析中考虑竞争风险的重要性:在老年房颤患者回顾性队列研究中对中风风险的应用
Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004580. doi: 10.1161/CIRCOUTCOMES.118.004580.
10
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.